Lv71
4470 积分 2023-06-23 加入
[Expert consensus on neoadjuvant therapy with short-course radiotherapy followed by chemotherapy combined with immunotherapy for patients with mismatch repair-proficient/microsatellite stable locally advanced rectal cancer (2025 edition)]
18天前
已完结
新辅助免疫治疗时代胃癌围手术期安全的新挑战:免疫相关不良事件与术后并发症的鉴别
2个月前
已完结
直肠癌新辅助免疫治疗相关不良反应临床诊治中国专家共识(2025版)
2个月前
已完结
直肠癌新辅助免疫治疗相关不良反应临床诊治中国专家共识
2个月前
已关闭
Association between immune-related side effects and efficacy and benefit of immune checkpoint inhibitors – A systematic review and meta-analysis
3个月前
已完结
Immune checkpoint therapy—current perspectives and future directions
3个月前
已完结
Nivolumab plus ipilimumab versus nivolumab in microsatellite instability-high metastatic colorectal cancer (CheckMate 8HW): a randomised, open-label, phase 3 trial
3个月前
已完结
Pembrolizumab versus chemotherapy in microsatellite instability-high or mismatch repair-deficient metastatic colorectal cancer: 5-year follow-up from the randomized phase III KEYNOTE-177 study
3个月前
已完结
COMMIT: A Randomized Study of mFOLFOX6/Bevacizumab/Atezolizumab or Atezolizumab Alone as First-Line Treatment of Deficient DNA Mismatch Repair Metastatic Colorectal Cancer
3个月前
已完结
Recurrence and survival following microwave, radiofrequency ablation, and hepatic resection of colorectal liver metastases: A systematic review and network meta-analysis
4个月前
已完结